Prevalence of type of drug reactions, and hypersensitivity to specific drug groups

Ozturk O. Aktas; E. Celebioglu; G. Karakaya; A. F. Kalyoncu

Prevalence of type of drug reactions, and hypersensitivity to specific drug groups

Ozturk O. Aktas
, E. Celebioglu
, G. Karakaya
, A. F. Kalyoncu

Hacettepe University

Araştırma çıktısı: Dergiye katkı › Toplantı Özeti › Hakem

Orijinal dil	İngilizce
Sayfa (başlangıç-bitiş)	809-809
Sayfa sayısı	1
Dergi	Allergy: European Journal of Allergy and Clinical Immunology
Hacim	73
Yayın durumu	Yayınlandı - Ağu 2018
Etkinlik	Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) - Munich, !!Germany Süre: 26 May 2018 → 30 May 2018

Diger dosyalar ve linkler

???wos.publication.link???

Bundan alıntı yap

@article{3bc0b04e20304486b948f4298ef863c8,

title = "Prevalence of type of drug reactions, and hypersensitivity to specific drug groups",

author = "Aktas, \{Ozturk O.\} and E. Celebioglu and G. Karakaya and Kalyoncu, \{A. F.\}",

year = "2018",

month = aug,

language = "English",

volume = "73",

pages = "809--809",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

note = "Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) ; Conference date: 26-05-2018 Through 30-05-2018",

}

TY - JOUR

T1 - Prevalence of type of drug reactions, and hypersensitivity to specific drug groups

AU - Aktas, Ozturk O.

AU - Celebioglu, E.

AU - Karakaya, G.

AU - Kalyoncu, A. F.

PY - 2018/8

Y1 - 2018/8

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000441690405278&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 0105-4538

VL - 73

SP - 809

EP - 809

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

T2 - Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)

Y2 - 26 May 2018 through 30 May 2018

ER -